1 | improving | 11,675 |
2 | optimizing | 716 |
3 | prolonging | 405 |
4 | maximizing | 277 |
5 | aiding | 148 |
6 | optimising | 122 |
7 | maximising | 43 |
8 | furthering | 35 |
9 | personalizing | 32 |
10 | expediting | 16 |
11 | remediating | 15 |
12 | debre | 5 |
13 | unguentum | 5 |
14 | decompressing | 4 |
15 | anaesthetising | 3 |
16 | corecem | 3 |
17 | h2n-mil-125 | 3 |
18 | infant/child | 3 |
19 | postchill | 3 |
20 | reexperience | 3 |
21 | sickness-induced | 3 |
22 | anticonvulsant-associated | 2 |
23 | cataract-induced | 2 |
24 | fluoxetine-related | 2 |
25 | hemodialysis-related | 2 |
26 | non-behavioural | 2 |
27 | object-identification | 2 |
28 | post-iis | 2 |
29 | prasat | 2 |
30 | slowing/preventing | 2 |
31 | solicits | 2 |
32 | target-aligned | 2 |
33 | tvf-free | 2 |
34 | amygdala-centered | 1 |
35 | cdc/national | 1 |
36 | dalcetrapib-mediated | 1 |
37 | dysfunctional/ineffective | 1 |
38 | early-stance | 1 |
39 | electronically-measured | 1 |
40 | emotion-dismissing | 1 |
41 | employees’ | 1 |
42 | end-treatment | 1 |
43 | endurance-based | 1 |
44 | eortc-qlq-c-30 | 1 |
45 | frontally-mediated | 1 |
46 | fully-catered | 1 |
47 | headline-gripping | 1 |
48 | high-hazard | 1 |
49 | hypermagnesemia-induced | 1 |
50 | knowledging | 1 |
51 | logotherapy-enhanced | 1 |
52 | medecins | 1 |
53 | metabolites-rich | 1 |
54 | mir173-programmed | 1 |
55 | moderate-to-strenuous | 1 |
56 | noncurricular | 1 |
57 | omega3/dha | 1 |
58 | parent-elicited | 1 |
59 | patient/investigator-reported | 1 |
60 | perioperative/late | 1 |
61 | pre-capitalist | 1 |
62 | pre-hospitalisation | 1 |
63 | rod-driven | 1 |
64 | scleroderma-specific | 1 |
65 | sensory-limbic | 1 |
66 | sf-6d/ | 1 |
67 | shear-resistant | 1 |
68 | stake/in | 1 |
69 | switch-related | 1 |
70 | tacrolimus-mediated | 1 |
71 | theoretically-meaningful | 1 |
72 | undertsanding | 1 |
73 | view-invariant | 1 |
74 | vivo-directed | 1 |
75 | youth-whose | 1 |
1 | aiding | 148 |
2 | amygdala-centered | 1 |
3 | anaesthetising | 3 |
4 | anticonvulsant-associated | 2 |
5 | cataract-induced | 2 |
6 | cdc/national | 1 |
7 | corecem | 3 |
8 | dalcetrapib-mediated | 1 |
9 | debre | 5 |
10 | decompressing | 4 |
11 | dysfunctional/ineffective | 1 |
12 | early-stance | 1 |
13 | electronically-measured | 1 |
14 | emotion-dismissing | 1 |
15 | employees’ | 1 |
16 | end-treatment | 1 |
17 | endurance-based | 1 |
18 | eortc-qlq-c-30 | 1 |
19 | expediting | 16 |
20 | fluoxetine-related | 2 |
21 | frontally-mediated | 1 |
22 | fully-catered | 1 |
23 | furthering | 35 |
24 | h2n-mil-125 | 3 |
25 | headline-gripping | 1 |
26 | hemodialysis-related | 2 |
27 | high-hazard | 1 |
28 | hypermagnesemia-induced | 1 |
29 | improving | 11,675 |
30 | infant/child | 3 |
31 | knowledging | 1 |
32 | logotherapy-enhanced | 1 |
33 | maximising | 43 |
34 | maximizing | 277 |
35 | medecins | 1 |
36 | metabolites-rich | 1 |
37 | mir173-programmed | 1 |
38 | moderate-to-strenuous | 1 |
39 | non-behavioural | 2 |
40 | noncurricular | 1 |
41 | object-identification | 2 |
42 | omega3/dha | 1 |
43 | optimising | 122 |
44 | optimizing | 716 |
45 | parent-elicited | 1 |
46 | patient/investigator-reported | 1 |
47 | perioperative/late | 1 |
48 | personalizing | 32 |
49 | post-iis | 2 |
50 | postchill | 3 |
51 | prasat | 2 |
52 | pre-capitalist | 1 |
53 | pre-hospitalisation | 1 |
54 | prolonging | 405 |
55 | reexperience | 3 |
56 | remediating | 15 |
57 | rod-driven | 1 |
58 | scleroderma-specific | 1 |
59 | sensory-limbic | 1 |
60 | sf-6d/ | 1 |
61 | shear-resistant | 1 |
62 | sickness-induced | 3 |
63 | slowing/preventing | 2 |
64 | solicits | 2 |
65 | stake/in | 1 |
66 | switch-related | 1 |
67 | tacrolimus-mediated | 1 |
68 | target-aligned | 2 |
69 | theoretically-meaningful | 1 |
70 | tvf-free | 2 |
71 | undertsanding | 1 |
72 | unguentum | 5 |
73 | view-invariant | 1 |
74 | vivo-directed | 1 |
75 | youth-whose | 1 |
1 | sf-6d/ | 1 |
2 | eortc-qlq-c-30 | 1 |
3 | h2n-mil-125 | 3 |
4 | omega3/dha | 1 |
5 | sensory-limbic | 1 |
6 | scleroderma-specific | 1 |
7 | logotherapy-enhanced | 1 |
8 | hypermagnesemia-induced | 1 |
9 | sickness-induced | 3 |
10 | cataract-induced | 2 |
11 | mir173-programmed | 1 |
12 | target-aligned | 2 |
13 | fully-catered | 1 |
14 | amygdala-centered | 1 |
15 | electronically-measured | 1 |
16 | endurance-based | 1 |
17 | anticonvulsant-associated | 2 |
18 | dalcetrapib-mediated | 1 |
19 | tacrolimus-mediated | 1 |
20 | frontally-mediated | 1 |
21 | fluoxetine-related | 2 |
22 | switch-related | 1 |
23 | hemodialysis-related | 2 |
24 | vivo-directed | 1 |
25 | parent-elicited | 1 |
26 | patient/investigator-reported | 1 |
27 | infant/child | 3 |
28 | high-hazard | 1 |
29 | early-stance | 1 |
30 | reexperience | 3 |
31 | tvf-free | 2 |
32 | debre | 5 |
33 | youth-whose | 1 |
34 | perioperative/late | 1 |
35 | dysfunctional/ineffective | 1 |
36 | aiding | 148 |
37 | undertsanding | 1 |
38 | knowledging | 1 |
39 | prolonging | 405 |
40 | headline-gripping | 1 |
41 | furthering | 35 |
42 | optimising | 122 |
43 | maximising | 43 |
44 | anaesthetising | 3 |
45 | decompressing | 4 |
46 | emotion-dismissing | 1 |
47 | remediating | 15 |
48 | expediting | 16 |
49 | slowing/preventing | 2 |
50 | improving | 11,675 |
51 | personalizing | 32 |
52 | optimizing | 716 |
53 | maximizing | 277 |
54 | metabolites-rich | 1 |
55 | cdc/national | 1 |
56 | non-behavioural | 2 |
57 | postchill | 3 |
58 | theoretically-meaningful | 1 |
59 | corecem | 3 |
60 | unguentum | 5 |
61 | rod-driven | 1 |
62 | stake/in | 1 |
63 | object-identification | 2 |
64 | pre-hospitalisation | 1 |
65 | noncurricular | 1 |
66 | post-iis | 2 |
67 | medecins | 1 |
68 | solicits | 2 |
69 | moderate-to-strenuous | 1 |
70 | prasat | 2 |
71 | view-invariant | 1 |
72 | shear-resistant | 1 |
73 | end-treatment | 1 |
74 | pre-capitalist | 1 |
75 | employees’ | 1 |